Sort by
Medicine and Dentistry
Polycystic Ovary Syndrome
100%
Cohort Analysis
47%
Androgen Therapy
24%
Placebo
24%
Gestational Diabetes
22%
Offspring
21%
Maturity Onset Diabetes of the Young
20%
Third Trimester Pregnancy
18%
Prevalence
18%
Hydrocortisone
18%
Body Mass Index
17%
Substitution Therapy
17%
Glycon
15%
Acromegaly
15%
Randomized Controlled Trial
14%
Insulin Resistance
13%
Bone Density
12%
Meta-Analysis
11%
Blood Pressure
11%
Cardiovascular Risk
10%
First Trimester Pregnancy
10%
Diabetes
10%
Cardiovascular System
10%
Hazard Ratio
10%
Androgen
10%
Cardiovascular Disease
9%
Pioglitazone
9%
Diseases
9%
Neoplasm
9%
Prolactin
9%
Placebo-Controlled Study
9%
Lean Body Weight
8%
Adiponectin
8%
Dual-Energy X-Ray Absorptiometry
8%
Prenatal Exposure
8%
Quality of Life
8%
Odds Ratio
7%
Hyperandrogenism
7%
Growth Hormone
7%
Hormone Therapy
7%
Oral Glucose Tolerance Test
7%
Mental Health
7%
Endocrine Disease
7%
Combination Therapy
7%
Bone Mineral
6%
Oral Contraceptive Agent
6%
Comorbidity
6%
Sex Hormone
6%
Infancy
6%
Sex Hormone Binding Globulin
5%
Biochemistry, Genetics and Molecular Biology
Bone Density
31%
Cohort Study
26%
Body Composition
24%
Insulin Resistance
17%
Blood Pressure
17%
Fat Mass
17%
Offspring
16%
Prevalence
16%
Body Mass
14%
Third Trimester Pregnancy
13%
Prolactin
12%
Insulin Sensitivity
11%
Pioglitazone
11%
First Trimester Pregnancy
9%
Bone Mass
9%
Lean Body Weight
8%
Reference Value
8%
Adiponectin
7%
Glucose Test
7%
Glucose Tolerance Test
7%
Genotyping
7%
Body Fat
7%
Glucose Metabolism
6%
Randomized Controlled Trial
6%
Cortisol
6%
Resistance Training
6%
Allele
6%
Bovine Somatotropin
6%
Growth Hormone
6%
Infancy
6%
Impaired Glucose Tolerance
6%
DNA Methylation
6%
Blood Plasma
6%
Skeletal Muscle
6%
Triglyceride
6%
X Ray
6%
Genetic Divergence
5%
Single-Nucleotide Polymorphism
5%
Prospective Study
5%
Blood Level
5%
Bone Strength
5%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Polycystic Disease
39%
Cohort Study
32%
Placebo
20%
Hydrocortisone
19%
Acromegaly
18%
Pregnancy Diabetes Mellitus
15%
Prolactin
12%
Diseases
11%
Replacement Therapy
11%
Prevalence
10%
Metformin
10%
Prenatal Exposure
9%
Glucocorticoid
8%
Perfluorooctanesulfonic Acid
8%
Perfluorononanoic Acid
7%
Thyrotropin
7%
Perfluorodecanoic Acid
6%
Non Insulin Dependent Diabetes Mellitus
6%
Neoplasm
6%
Comorbidity
6%
Oral Contraceptive Agent
6%
Hyperprolactinemia
6%
Oral Contraceptive
6%
Combination Therapy
6%
Placebo-Controlled Study
6%
Luteinizing Hormone
5%
Perfluorooctanoic Acid
5%
Adiponectin
5%
Thyroid Hormone
5%
Pioglitazone
5%
Octreotide
5%
